mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.36 |
0.03 |